An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.
Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company which provides biological research reagents and related technical contract research services, announced a successful listing on the Shenzhen Stock Exchange subsidiary ChiNext under the stock abbreviation Sino Biological and stock code 301047. A total of 17 million shares were issued for a total of 4.98 billion RMB raised during this initial public offering.
Evidence is mounting that epigenetic marks on DNA can influence future generations in a variety of ways. But how such phenomena might affect large-scale evolutionary processes is hotly debated.
As more researchers flock to the popular field, observers fear a widening gap between supply and demand When scientists convene in New Orleans next week for the 33rd annual meeting of the American Society for Cell Biology (ASCB), nine symposia, 20 minisymposia, and countless informal gatherings are sure to focus on the recent achievements and continuing progress in this exciting and rapidly expanding scientific field. There is likely to be little excitement in the air, however, concerning the
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.